Cargando…

Correction: Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling

Detalles Bibliográficos
Autores principales:	Huang, Zixian, Rui, Xi, Yi, Chen, Chen, Yongju, Chen, Rui, Liang, Yancan, Wang, Yan, Yao, Weicheng, Xu, Xiaoding, Huang, Zhiquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134512/ https://www.ncbi.nlm.nih.gov/pubmed/37106361 http://dx.doi.org/10.1186/s13046-023-02679-0

Ejemplares similares

Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling
por: Huang, Zixian, et al.
Publicado: (2023)

Correction: Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3
por: Huang, Zixian, et al.
Publicado: (2020)

Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3
por: Huang, Zixian, et al.
Publicado: (2019)

RPS3 Promotes the Metastasis and Cisplatin Resistance of Adenoid Cystic Carcinoma
por: Rui, Xi, et al.
Publicado: (2022)

GSDMD enhances cisplatin-induced apoptosis by promoting the phosphorylation of eIF2α and activating the ER-stress response
por: Zhang, Qianyu, et al.
Publicado: (2022)

HPV Enhances HNSCC Chemosensitization by Inhibiting SERPINB3 Expression to Disrupt the Fanconi Anemia Pathway
por: Huang, Zixian, et al.
Publicado: (2022)

Vitamin D inhibits the proliferation of Oral Squamous Cell Carcinoma by suppressing lncRNA LUCAT1 through the MAPK pathway
por: Jin, Tingting, et al.
Publicado: (2020)

CD79A work as a potential target for the prognosis of patients with OSCC: analysis of immune cell infiltration in oral squamous cell carcinoma based on the CIBERSORTx deconvolution algorithm
por: Yao, Shucong, et al.
Publicado: (2023)

Stroke Exacerbates Cancer Progression by Upregulating LCN2 in PMN-MDSC
por: Huang, Tingting, et al.
Publicado: (2020)

The effect of lipocalin-2 (LCN2) on apoptosis: a proteomics analysis study in an LCN2 deficient mouse model
por: Wu, Dongming, et al.
Publicado: (2021)

The role of LCN2 and LCN2-MMP9 in spondylitis radiographic development: gender and HLA-B27 status differences
por: Tsui, Florence W. L., et al.
Publicado: (2022)

Correction to: Exosomes derived from microRNA-138-5poverexpressing bone marrow-derived mesenchymal stem cells confer neuroprotection to astrocytes following ischemic stroke via inhibition of LCN2
por: Deng, Yiming, et al.
Publicado: (2022)

Correction to: Developing fast enzyme recycling strategy through elucidating enzyme adsorption kinetics on alkali and acid pretreated corn stover
por: Yuan, Ye, et al.
Publicado: (2018)

Network based analyses of gene expression profile of LCN2 overexpression in esophageal squamous cell carcinoma
por: Wu, Bingli, et al.
Publicado: (2014)

Identification, characterization and expression analysis of rLcn13, an epididymal lipocalin in rats : Characterization of epididymal-specific lipicalin rLcn13
por: Yao, Guangxin, et al.
Publicado: (2023)

LCN2 is a new diagnostic biomarker and potential therapeutic target in idiopathic short stature
por: Liu, Xijuan, et al.
Publicado: (2022)

MicroRNA-761 suppresses remodeling of nasal mucosa and epithelial–mesenchymal transition in mice with chronic rhinosinusitis through LCN2
por: Cheng, Jinzhang, et al.
Publicado: (2020)

LncRNA HOXA-AS2 Promotes Tumor Progression by Suppressing miR-567 Expression in Oral Squamous Cell Carcinoma
por: Chen, Rui, et al.
Publicado: (2021)

Nucleus‐specific RNAi nanoplatform for targeted regulation of nuclear lncRNA function and effective cancer therapy
por: Huang, Zixian, et al.
Publicado: (2022)

Correction for: Silencing DSCAM-AS1 suppresses the growth and invasion of ER-positive breast cancer cells by downregulating both DCTPP1 and QPRT
por: Yue, Zhang, et al.
Publicado: (2022)

LCN6, a novel human epididymal lipocalin
por: Hamil, Katherine G, et al.
Publicado: (2003)

Resistance to the Bacteriocin Lcn972 Deciphered by Genome Sequencing
por: Escobedo, Susana, et al.
Publicado: (2023)

Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker
por: Chiang, Kun-Chun, et al.
Publicado: (2016)

Correction: Correlation between musculoskeletal mass and perfusion in patients with gastrointestinal malignancy: a preliminary study based on quantitative CT and CT perfusion
por: Ji, Rui, et al.
Publicado: (2022)

Correction for: Tomatidine suppresses inflammation in primary articular chondrocytes and attenuates cartilage degradation in osteoarthritic rats
por: Chu, Xiangyu, et al.
Publicado: (2022)

High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma
por: Xie, Guo-feng, et al.
Publicado: (2020)

Correction to: LncRNA NEAT1 mediates progression of oral squamous cell carcinoma via VEGF-A and Notch signaling pathway
por: He, Ke, et al.
Publicado: (2020)

TGF-β-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2
por: Wang, Feng, et al.
Publicado: (2021)

LCN2 as a Potential Diagnostic Biomarker for Ulcerative Colitis-Associated Carcinogenesis Related to Disease Duration
por: Kou, Fushun, et al.
Publicado: (2022)

Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109
por: Yu, Albert, et al.
Publicado: (2022)

Correction to: TRAP1 suppresses oral squamous cell carcinoma progression by reducing oxidative phosphorylation metabolism of Cancer-associated fibroblasts
por: Xiao, Li, et al.
Publicado: (2021)

Inhibition of VEGFR2 and EGFR signaling cooperatively suppresses the proliferation of oral squamous cell carcinoma
por: Onda, Maho, et al.
Publicado: (2023)

Correction: Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance
por: Shang, Chao, et al.
Publicado: (2022)

NOX activation in reactive astrocytes regulates astrocytic LCN2 expression and neurodegeneration
por: Liu, Ruijia, et al.
Publicado: (2022)

Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy
por: Asimakopoulou, Anastasia, et al.
Publicado: (2016)

Chronic diazepam administration increases the expression of Lcn2 in the CNS
por: Furukawa, Tomonori, et al.
Publicado: (2017)

Correction: Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways
por: Yang, Jianhong, et al.
Publicado: (2020)

Silencing of LINC01116 suppresses the development of oral squamous cell carcinoma by up-regulating microRNA-136 to inhibit FN1
por: Chen, Zhifeng, et al.
Publicado: (2019)

SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling
por: Barzegar, Mansoureh, et al.
Publicado: (2017)

Application of an L-shaped anterolateral thigh flap in reconstruction after hemiglossectomy
por: Rui, Xi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3tfslt9541nmf94uimh09s29lv